Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Hospital surgical volume, utilization, costs and outcomes of retroperitoneal lymph node dissection for testis cancer.

Yu HY, Hevelone ND, Patel S, Lipsitz SR, Hu JC.

Adv Urol. 2012;2012:189823. doi: 10.1155/2012/189823. Epub 2012 Apr 9.

2.

Hospital volume, utilization, costs and outcomes of robot-assisted laparoscopic radical prostatectomy.

Yu HY, Hevelone ND, Lipsitz SR, Kowalczyk KJ, Nguyen PL, Hu JC.

J Urol. 2012 May;187(5):1632-7. doi: 10.1016/j.juro.2011.12.071. Epub 2012 Mar 14.

PMID:
22425094
3.

Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique.

Stepanian S, Patel M, Porter J.

Eur Urol. 2016 Oct;70(4):661-667. doi: 10.1016/j.eururo.2016.03.031. Epub 2016 Apr 5.

PMID:
27068395
4.

Laparoscopic retroperitoneal lymph node dissection for low-stage cancer: a Washington University update.

Gardner MW, Roytman TM, Chen C, Brandes SB, Kibel AS, Grubb RL, Bhayani SB, Figenshau RS.

J Endourol. 2011 Nov;25(11):1753-7. doi: 10.1089/end.2010.0596. Epub 2011 Sep 21.

PMID:
21936630
5.

Laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.

Rassweiler JJ, Scheitlin W, Heidenreich A, Laguna MP, Janetschek G.

Eur Urol. 2008 Nov;54(5):1004-15. doi: 10.1016/j.eururo.2008.08.022. Epub 2008 Aug 13. Review.

PMID:
18722704
6.

Patterns of performance of retroperitoneal lymph node dissections by American urologists: most retroperitoneal lymph node dissections in the United States are performed by low-volume surgeons.

Flum AS, Bachrach L, Jovanovic BD, Helenowski IB, Flury SC, Meeks JJ.

Urology. 2014 Dec;84(6):1325-8. doi: 10.1016/j.urology.2014.07.054. Epub 2014 Oct 11.

PMID:
25306483
7.

Utilization of retroperitoneal lymph node dissection for testicular cancer in the United States: Results from the National Cancer Database (1998-2011).

Hugen CM, Hu B, Jeldres C, Burton C, Nichols CR, Porter CR, Daneshmand S.

Urol Oncol. 2016 Nov;34(11):487.e7-487.e11. doi: 10.1016/j.urolonc.2016.05.036. Epub 2016 Jun 29.

PMID:
27372281
8.

Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer.

Pearce SM, Golan S, Gorin MA, Luckenbaugh AN, Williams SB, Ward JF, Montgomery JS, Hafez KS, Weizer AZ, Pierorazio PM, Allaf ME, Eggener SE.

Eur Urol. 2017 Mar;71(3):476-482. doi: 10.1016/j.eururo.2016.05.017. Epub 2016 May 24.

PMID:
27234998
9.

Trans- and extraperitoneal retroperitoneal lymph node dissection (RPLND) in the treatment for nonseminomatous germ cell testicular tumors (NSGCT): a single Chinese center's retrospective analysis.

Tong S, Chen M, Zu X, Li Y, He W, Lei Y, Liu W, Qi L.

Int Urol Nephrol. 2014 Feb;46(2):363-9. doi: 10.1007/s11255-013-0547-3. Epub 2013 Sep 1.

PMID:
23996573
10.

[Retroperitoneal surgery in the treatment of germ-cell tumors of the testis: retroperitoneal lymph node dissection (RPLND)].

Nicolai N, Necchi A, Piva L, Stagni S, Catanzaro MA, Biasoni D, Milani A, Torelli T, Salvioni R.

Urologia. 2010 Apr-May;77(2):84-7. Review. Italian.

PMID:
20890864
11.

Post-chemotherapy laparoscopic retroperitoneal lymph node dissection is feasible for stage IIA/B non-seminoma germ cell tumors.

Nakamura T, Kawauchi A, Oishi M, Ueda T, Shiraishi T, Nakanishi H, Kamoi K, Naya Y, Hongo F, Okihara K, Miki T.

Int J Clin Oncol. 2016 Aug;21(4):791-5. doi: 10.1007/s10147-015-0934-0. Epub 2015 Dec 23.

PMID:
26701172
12.

Postchemotherapy laparoscopic retroperitoneal lymph node dissection for low-volume, stage II, nonseminomatous germ cell tumor: first 100 patients.

Steiner H, Leonhartsberger N, Stoehr B, Peschel R, Pichler R.

Eur Urol. 2013 Jun;63(6):1013-7. doi: 10.1016/j.eururo.2012.09.036. Epub 2012 Sep 24.

PMID:
23021090
13.

Retroperitoneal Lymph Node Dissection as First-Line Treatment of Node-Positive Seminoma.

Hu B, Shah S, Shojaei S, Daneshmand S.

Clin Genitourin Cancer. 2015 Aug;13(4):e265-9. doi: 10.1016/j.clgc.2015.01.002. Epub 2015 Jan 21.

PMID:
25682512
14.

Complications of post-chemotherapy retroperitoneal lymph node dissection for testis cancer.

Mosharafa AA, Foster RS, Koch MO, Bihrle R, Donohue JP.

J Urol. 2004 May;171(5):1839-41.

PMID:
15076289
15.

A comparative analysis of robotic vs laparoscopic retroperitoneal lymph node dissection for testicular cancer.

Harris KT, Gorin MA, Ball MW, Pierorazio PM, Allaf ME.

BJU Int. 2015 Dec;116(6):920-3. doi: 10.1111/bju.13121. Epub 2015 May 25.

16.

Open versus laparoscopic retroperitoneal lymph node dissection: assessing adequacy of dissection in a porcine model.

Benway BM, Diaz DL, Katz MD, Vardi IY, Chavla NT, Desai AC, Badwan KH, Maxwell KL, Baca G, Humphrey PA, Bhayani SB, Figenshau RS.

J Endourol. 2009 Mar;23(3):485-8. doi: 10.1089/end.2008.0036.

PMID:
19193133
17.

Retroperitoneal lymph node dissection: an update in testicular malignancies.

Yadav K.

Clin Transl Oncol. 2017 Feb 1. doi: 10.1007/s12094-017-1622-5. [Epub ahead of print] Review.

PMID:
28150168
18.
19.

Robot-assisted retroperitoneal lymph node dissection: technique and initial case series of 18 patients.

Cheney SM, Andrews PE, Leibovich BC, Castle EP.

BJU Int. 2015 Jan;115(1):114-20. doi: 10.1111/bju.12804. Epub 2014 Aug 16.

20.

[Post-chemotherapy laparoscopic retroperitoneal lymph node dissection in low volume residual germ cell cancer: a technique to reduce morbidity].

Aufderklamm S, Todenhöfer T, Hennenlotter J, Gakis G, Mischinger J, Mundhenk J, Germann M, Stenzl A, Schwentner C.

Urologe A. 2013 Aug;52(8):1097-103. doi: 10.1007/s00120-013-3133-5. German.

PMID:
23416965

Supplemental Content

Support Center